Bionure Farma SL-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011888
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bionure Farma SL (Bionure) is a healthcare service provider that provides treatment for ophthalmological diseases, with concentration on multiple sclerosis and glaucoma. The company concentrates on two conditions of vision impairment which include optic neuritis and neuromyelitis optica. Its lead candidate BN201 is being developed for the treatment of multiple sclerosis and other neurological and ophthalmological diseases. Bionure also identifies biomarkers to diagnose the disease, and to be used in prognostic and predictive tests. The comapny partners with Fundacio GAEM, Fast Forward LLC, Reig Jofre, National Multiple Sclerosis Society and Myelin Repair Foundation (MRF). The company has operations in the US and Spain. Bionure is headquartered in Barcelona, Spain.

Bionure Farma SL – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bionure Farma SL, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bionure Farma SL, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Bionure Farma SL, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bionure Farma SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Bionure Farma SL, Medical Devices Deals, 2011 to YTD 2017 9
Bionure Farma SL, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Bionure Farma SL, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Bionure Raises USD30 Million in Series A Financing 11
Bionure Raises US$2 Million In Seed Financing 12
Partnerships 13
Bionure Enters into Research Agreement with Fast Forward 13
Myelin Repair Foundation Enters Into Agreement With Bionure For Multiple Sclerosis 14
Asset Transactions 15
Spiral Therapeutics to Acquire Rights to Two Neuroprotective Agents from Bionure Farma 15
Bionure Farma SL – Key Competitors 16
Bionure Farma SL – Key Employees 17
Bionure Farma SL – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Bionure Farma SL, Pharmaceuticals & Healthcare, Key Facts 2
Bionure Farma SL, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bionure Farma SL, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Bionure Farma SL, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bionure Farma SL, Deals By Therapy Area, 2011 to YTD 2017 8
Bionure Farma SL, Medical Devices Deals, 2011 to YTD 2017 9
Bionure Farma SL, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Bionure Raises USD30 Million in Series A Financing 11
Bionure Raises US$2 Million In Seed Financing 12
Bionure Enters into Research Agreement with Fast Forward 13
Myelin Repair Foundation Enters Into Agreement With Bionure For Multiple Sclerosis 14
Spiral Therapeutics to Acquire Rights to Two Neuroprotective Agents from Bionure Farma 15
Bionure Farma SL, Key Competitors 16
Bionure Farma SL, Key Employees 17

★海外企業調査レポート[Bionure Farma SL-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Under Armour Inc (UAA):企業の財務・戦略的SWOT分析
    Under Armour Inc (UAA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Dana-Farber Cancer Institute Inc:企業のM&A・事業提携・投資動向
    Dana-Farber Cancer Institute Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dana-Farber Cancer Institute Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Bush Industries Inc:企業の戦略・SWOT・財務分析
    Bush Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Bush Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Nahar Industrial Enterprises Limited (NAHARINDUS):企業の財務・戦略的SWOT分析
    Nahar Industrial Enterprises Limited (NAHARINDUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Teva Pharmaceutical Industries Limited:企業のM&A・事業提携・投資動向
    Teva Pharmaceutical Industries Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Teva Pharmaceutical Industries Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • Mondelez International Inc (MDLZ):企業の財務・戦略的SWOT分析
    Mondelez International Inc (MDLZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • FieldPoint Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    FieldPoint Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary FieldPoint Petroleum Corp (FieldPoint) is an oil and gas company that acquires, operates and develops oil and gas properties. The company’s acquisition includes leasehold and working intere …
  • Columbus Energy Resources PLC (CERP):石油・ガス:M&Aディール及び事業提携情報
    Summary Columbus Energy Resources PLC (Columbus Energy), formerly LGO Energy Plc is an oil and gas exploration and development company. The company acquires, explores, develops and produces oil and gas properties. It operates oil and gas assets in Trinidad including the South West Peninsula licenses …
  • One Lambda Inc-医療機器分野:企業M&A・提携分析
    Summary One Lambda Inc (One Lambda), a subsidiary of Thermo Fisher Scientific Inc is a medical device company that offers laboratory products. The company develops and distributes histocompatibility typing tests and antibody detection products. Its products include HLA tissue typing trays, HLA testi …
  • Intuit Inc (INTU):企業の財務・戦略的SWOT分析
    Intuit Inc (INTU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Ramsay Health Care Ltd (RHC):企業の財務・戦略的SWOT分析
    Ramsay Health Care Ltd (RHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Banco Hipotecario SA (BHIP3):企業の財務・戦略的SWOT分析
    Banco Hipotecario SA (BHIP3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Praxair Inc (PX)-石油・ガス分野:企業M&A・提携分析
    Summary Praxair Inc (Praxair) is a producer and supplier of industrial gases. The company offers atmospheric gases including oxygen, nitrogen, argon and rare gases, and process gases such as carbon dioxide, helium, hydrogen, electronic gases, specialty gases and acetylene. It also designs and builds …
  • Karolinska University Hospital-製薬・医療分野:企業M&A・提携分析
    Summary Karolinska University Hospital (KUH), a subsidiary of Karolinska Institutet is a healthcare service provider that offers patient care, research and education programs. The hospital offers cross border medical care by referring patients or by tele medicine and health care at a distance. It of …
  • Lucigen Corp:企業の製品パイプライン分析2018
    Summary Lucigen Corp (Lucigen), a subsidiary of LGC Ltd, is a medical device company that discovers, manufactures, and commercializes molecular biology product. The company’s products comprise competent cells, nextgen seq, enzymes, cloning systems, PCR and amplification, cloning test kits and vector …
  • Cassava Sciences Inc (SAVA):企業の財務・戦略的SWOT分析
    Cassava Sciences Inc (SAVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • BTA Bank JSC:企業の戦略・SWOT・財務情報
    BTA Bank JSC - Strategy, SWOT and Corporate Finance Report Summary BTA Bank JSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Singulex Inc:企業の製品パイプライン分析2018
    Summary Singulex Inc (Singulex) is a medical device company develops single molecule counting technology. The company provides Sgx clarity system, an in vitro diagnostics platform that provides high sensitivity next generation immunodiagnostics. Its proprietary SMC technology allows scientists and p …
  • Allied Cooperative Insurance Group:企業の戦略・SWOT・財務情報
    Allied Cooperative Insurance Group - Strategy, SWOT and Corporate Finance Report Summary Allied Cooperative Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Dynavax Technologies Corp (DVAX):企業の財務・戦略的SWOT分析
    Dynavax Technologies Corp (DVAX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆